Sources Sought Notice Alcor ISED Elite ESR analyzer

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

NAVAJO AREA INDIAN HEALTH SVC

Contract Value

Not provided

Codes & Classification
Solicitation Number

SSNIHS1522413

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Classification Code

-

Additional Details
Set Aside

None

Place of Performance

Chinle, Arizona, UNITED STATES

SourceSAM
The Indian Health Service (IHS), Chinle Service Unit, is conducting a market research effort through a Sources Sought Notice to identify qualified vendors for the placement of one Alcor ISED Elite ESR analyzer (model 112-00222P) at its facility in Chinle, Arizona. This initiative is intended to support the diagnostic needs of the Chinle Service Unit by securing an instrument placement agreement on a cost-per-test basis, with associated supplies to be procured as needed. The primary objective is to ensure reliable access to in-vitro diagnostic testing capabilities, specifically erythrocyte sedimentation rate (ESR) analysis, which is critical for patient care within the IHS system. The scope of this notice encompasses the identification of Indian-owned Economic Enterprises (IEEs), both large and small (ISBEEs), as well as other capable firms, who can provide the specified analyzer and support the ongoing supply requirements. The IHS is particularly interested in responses from Indian-owned businesses, in alignment with the Buy Indian Act (25 U.S.C. 47), and will prioritize these entities in its acquisition strategy. Should sufficient Indian-owned sources not be identified, the contracting office will consider set-aside programs under the Small Business Act. Key requirements for respondents include the ability to provide the Alcor ISED Elite ESR analyzer under an instrument placement (cost-per-test) model, as well as the capacity to supply consumables on an as-needed basis. Interested parties must demonstrate their technical capability and relevant experience, including current or past performance on similar contracts, and may reference established agreements such as GSA or VA Schedules. Indian-owned businesses must also submit a completed IHS IEE Representation Form in accordance with HHSAR 326.606-1(b). The applicable North American Industry Classification System (NAICS) code for this requirement is 325413 – In-Vitro Diagnostic Substance Manufacturing, with a small business size standard of 1,250 employees. The place of performance is Chinle, Arizona. This notice is issued solely for market research purposes and does not constitute a solicitation or a request for proposals. The information gathered will inform the contracting office’s acquisition strategy, including potential competition, set-asides, and the identification of qualified Indian-owned economic enterprises. Participation in this sources sought process is voluntary, and the government will not reimburse any costs incurred in responding. Interested vendors must be registered in the System for Award Management (SAM.gov) at the time of submission and award, in accordance with FAR 4.203-1(b). Submissions should include a comprehensive company profile (including UEI, contact information, business size and ownership type, socio-economic status, Native American ownership identification, and SAM.gov certifications), a statement of capability, and, if applicable, the IHS IEE Representation Form. Responses are to be submitted by April 24, 2026, 5:00pm MST, to Nora Nutlouis, Purchasing Agent, at [email protected], with the subject line “SSN - IHS1522413.” Telephone inquiries will not be accepted, and no feedback will be provided regarding submissions. The contracting entity for this opportunity is the Navajo Area Indian Health Service, a federal office under the Department of Health and Human Services, Indian Health Service. The primary point of contact is Nora Nutlouis, who can be reached at (928) 725-9806 or via email. For further details, interested parties may refer to the official notice at: https://sam.gov/opp/a0051a21dd73455dbf714fc57bca1b0b/view.